Reuters -- Biopharmaceutical company Genta Inc said it expects to run out of funds in June and could be required to reduce its workforce or file for bankruptcy, among other options, if it is unable to raise money.
Reuters -- Biopharmaceutical company Genta Inc said it expects to run out of funds in June and could be required to reduce its workforce or file for bankruptcy, among other options, if it is unable to raise money.
